Quality cell lines, by design.
Off-the-shelf iPSC lines manufactured under GMP from start to finish.
GMP-compliant iPSC Lines
Our team of iPSC experts has spent more than a decade rigorously developing an iPSC platform. Manufactured in compliance with GMP, our iPSC lines provide therapeutic developers with high-quality, reliable starting material for manufacturing cell therapies, accelerating GMP reprogramming development timelines by 12 months and cutting cell line development costs by up to 60 per cent.
Our Platform
Position your cell therapy for success with our GMP iPSC lines
GMP-compliant iPSC lines
GMP manufacturing throughout the entire process, with the end in mind. All reagents are GMP with full traceability.
We enhance regulatory compliance.
Access to Experts
Access our iPSC experts during your evaluation of our cell lines to support cell line selection.
We enhance clinical translation.
Genetic Safety Data
Evaluation of culture-induced abnormalities and genetic stability at high passage number.
We enhance drug product safety.
Transparent and Flexible Terms
Visibility on licensing terms during the evaluation phase and flexibility on structuring the license.
We enhance your business planning.
Submission Ready
Drug master file that can be cross-referenced in regulatory submissions to ensure your CMC data package is complete.
We enhance your regulatory submission.
iPSC Lines Tailored to Your Needs
Accelerate your time to GMP and to the clinic with the right line, under the right terms. LineaBio offers cell therapy developers with flexibility for both unmodified and gene-edited iPSC lines, providing either non-exclusive or exclusive licenses using a customized pricing model, supported by drug master files.